Screener
MapLight Therapeutics, Inc. MPLT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:25 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224129
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $3,188 | $3,289 |
| Accrued expenses | 10,175 | 12,049 |
| Lease liability - current | 920 | 891 |
| Total current liabilities | 14,283 | 16,229 |
| Lease liability - noncurrent | 4,671 | 4,911 |
| Total liabilities | 18,954 | 21,140 |
| Commitments and contingencies (Note 11) | ||
| Stockholders' equity: |
Item 1. Financial Statements.
FAQ
- What is MapLight Therapeutics, Inc.'s total current liabilities?
- MapLight Therapeutics, Inc. (MPLT) reported total current liabilities of $14.28M in Q1 2026.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about MapLight Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude